1
|
Evers J, Sridhar K, Liegey J, Brady J, Jahns H, Lowery M. Stimulation-induced changes at the electrode-tissue interface and their influence on deep brain stimulation. J Neural Eng 2022; 19. [PMID: 35728575 DOI: 10.1088/1741-2552/ac7ad6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Accepted: 06/21/2022] [Indexed: 11/12/2022]
Abstract
OBJECTIVE During deep brain stimulation (DBS) the electrode-tissue interface forms a critical path between device and brain tissue. Although changes in the electrical double layer and glial scar can impact stimulation efficacy, the effects of chronic DBS on the electrode-tissue interface have not yet been established. APPROACH In this study, we characterised the electrode-tissue interface surrounding chronically implanted DBS electrodes in rats and compared the impedance and histological properties at the electrode interface in animals that received daily stimulation and in those where no stimulation was applied, up to eight weeks post-surgery. A computational model was developed based on the experimental data, which allowed the dispersive electrical properties of the surrounding encapsulation tissue to be estimated. The model was then used to study the effect of stimulation-induced changes in the electrode-tissue interface on the electric field and neural activation during voltage- and current-controlled stimulation. MAIN RESULTS Incorporating the observed changes in simulations in silico, we estimated the frequency-dependent dielectric properties of the electrical double layer and surrounding encapsulation tissue. Through simulations we show how stimulation-induced changes in the properties of the electrode-tissue interface influence the electric field and alter neural activation during voltage-controlled stimulation. A substantial increase in the number of stimulated collaterals, and their distance from the electrode, was observed during voltage-controlled stimulation with stimulated ETI properties. In vitro examination of stimulated electrodes confirmed that high frequency stimulation leads to desorption of proteins at the electrode interface, with a concomitant reduction in impedance. SIGNIFICANCE The demonstration of stimulation-induced changes in the electrode-tissue interface has important implications for future DBS systems including closed-loop systems where the applied stimulation may change over time. Understanding these changes is particularly important for systems incorporating simultaneous stimulation and sensing, which interact dynamically with brain networks.
Collapse
Affiliation(s)
- J Evers
- School of Electrical and Electronic Engineering, University College Dublin, Engineering Building, UCD Belfield, Dublin, Dublin, 4, IRELAND
| | - K Sridhar
- School of Electrical and Electronic Engineering, University College Dublin, Engineering Building, UCD Belfield, Dublin, Dublin, 4, IRELAND
| | - J Liegey
- School of Electrical and Electronic Engineering, University College Dublin, Engineering Building, UCD Belfield, Dublin, Dublin, 4, IRELAND
| | - J Brady
- School of Veterinary Medicine, University College Dublin, Veterinary Science Center, Dublin, 4, IRELAND
| | - H Jahns
- School of Veterinary Medicine, University College Dublin, Veterinary Science Center, Dublin, 4, IRELAND
| | - M Lowery
- School of Electrical, Electronic & Mechancial Engineering, University College Dublin, Engineering & Materials Science Centre, Belfield, Dublin 4, Dublin, 4, IRELAND
| |
Collapse
|
2
|
Goffe K, Wilson J, Gluck T, Brady J, Burns A, Bergbaum C, Petra H, Stewart M, Wilson E. 779 IMPROVING USE OF COORDINATE MY CARE USING A QUALITY IMPROVEMENT APPROACH FOR MEDICAL PATIENTS ADMITTED TO BARNET HOSPITAL. Age Ageing 2022. [DOI: 10.1093/ageing/afac034.779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Coordinate My Care (CMC) is a digital care plan for communicating person-centred urgent and advance care planning. We recognised that it was not being consistently accessed on admission, nor updated on discharge, leading to a risk of ignoring patient wishes and previously clinician-agreed care plans. We used a quality improvement approach to increase use of CMC.
Method
We gathered baseline data on the number of users utilising their account, and explored current practice and barriers. A driver diagram was developed, a Steering Group met regularly, and interventions were tested using Plan, Do, Study, Act. Interventions began in January 2021, including electronic circulation of a guide to gain access to CMC, posters about CMC, departmental teaching, and drop-in training. A Core Group of clinicians repeatedly surveyed 12 medical ward areas and offered on-the-spot troubleshooting. To mitigate effects of staff turnover, we developed e-classroom training for new starters.
Results
53 people attended departmental teaching and drop-ins. The number of users utilising their account each month showed a steady increase, rising from 25 to 42 users. Monthly views of CMC records are increasing, with 167 in May 2021 compared to an average of 105 in the 5 months prior to the project. We have still to examine patient feedback.
Conclusion
Use of CMC is becoming more established. Future actions will concentrate on training (including in the emergency department and during junior doctor changeover), helping clinicians hold conversations, and establishing mentoring. Recording Advance Care Planning on CMC is a final step in a complex process of identifying that a patient may be in the last year of their life, starting conversations and taking actions. It follows that varied and sustained actions are needed to improve this, in order to realise the benefits of person-centred planning for our patients and those caring for them.
Collapse
Affiliation(s)
- K Goffe
- Barnet Hospital, Royal Free London NHS Trust
| | - J Wilson
- Barnet Hospital, Royal Free London NHS Trust
| | - T Gluck
- Barnet Hospital, Royal Free London NHS Trust
| | - J Brady
- Barnet Hospital, Royal Free London NHS Trust
| | - A Burns
- Barnet Hospital, Royal Free London NHS Trust
| | - C Bergbaum
- Barnet Hospital, Royal Free London NHS Trust
| | - H Petra
- Barnet Hospital, Royal Free London NHS Trust
| | - M Stewart
- Barnet Hospital, Royal Free London NHS Trust
| | - E Wilson
- Barnet Hospital, Royal Free London NHS Trust
| |
Collapse
|
3
|
PALAZZI X, Pardo I, Sirivelu M, Newman L, Kumpf S, Qian J, Franks T, Lopes S, Liu J, Monarski L, Casinghino S, Ritenour C, Ritenour H, Dubois C, Olson J, Graves J, Alexander K, Coskran T, Lanz TA, Brady J, McCarty D, Somanathan S, Whiteley L. Biodistribution and Tolerability of AAV-PHP.B-CBh-SMN1 in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles. Hum Gene Ther 2021; 33:175-187. [PMID: 34931542 PMCID: PMC8885435 DOI: 10.1089/hum.2021.116] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Recombinant adeno-associated viruses (AAVs) have emerged as promising vectors for human gene therapy, but some variants have induced severe toxicity in Rhesus monkeys and piglets following high-dose intravenous (IV) administration. To characterize biodistribution, transduction, and toxicity among common preclinical species, an AAV9 neurotropic variant expressing the survival motor neuron 1 (SMN1) transgene (AAV-PHP.B-CBh-SMN1) was administered by IV bolus injection to Wistar Han rats and cynomolgus monkeys at doses of 2 × 1013, 5 × 1013, or 1 × 1014 vg/kg. A dose-dependent degeneration/necrosis of neurons without clinical manifestations occurred in dorsal root ganglia (DRGs) and sympathetic thoracic ganglia in rats, while liver injury was not observed in rats. In monkeys, one male at 5 × 1013 vg/kg was found dead on day 4. Clinical pathology data on days 3 and/or 4 at all doses suggested liver dysfunction and coagulation disorders, which led to study termination. Histologic evaluation of the liver in monkeys showed hepatocyte degeneration and necrosis without inflammatory cell infiltrates or intravascular thrombi, suggesting that hepatocyte injury is a direct effect of the vector following hepatocyte transduction. In situ hybridization demonstrated a dose-dependent expression of SMN1 transgene mRNA in the cytoplasm and DNA in the nucleus of periportal to panlobular hepatocytes, while quantitative polymerase chain reaction confirmed the dose-dependent presence of SMN1 transgene mRNA and DNA in monkeys. Monkeys produced a much greater amount of transgene mRNA compared with rats. In DRGs, neuronal degeneration/necrosis and accompanying findings were observed in monkeys as early as 4 days after test article administration. The present results show sensory neuron toxicity following IV delivery of AAV vectors at high doses with an early onset in Macaca fascicularis and after 1 month in rats, and suggest adding the autonomic system in the watch list for preclinical and clinical studies. Our data also suggest that the rat may be useful for evaluating the potential DRG toxicity of AAV vectors, while acute hepatic toxicity associated with coagulation disorders appears to be highly species-dependent.
Collapse
Affiliation(s)
- Xavier PALAZZI
- Pfizer Global Research and Development, 105623, 1, Eastern Point Road, Groton, Connecticut, United States, 06340
| | - Ingrid Pardo
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Madhu Sirivelu
- Pfizer Worldwide Research Development and Medicine, Drug Safety Research and Development, Cambridge, Massachusetts, United States
| | - Leah Newman
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Steven Kumpf
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Jessie Qian
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Tania Franks
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Sarah Lopes
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - June Liu
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Laura Monarski
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Sandra Casinghino
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Casey Ritenour
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Hayley Ritenour
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Christopher Dubois
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Jennifer Olson
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - John Graves
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Kristin Alexander
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Timothy Coskran
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Thomas A Lanz
- Pfizer Global Research and Development, 105623, Groton, Connecticut, United States
| | - Joseph Brady
- Pfizer Worldwide Research Development and Medicine, Drug Safety Research and Development, Cambridge, Massachusetts, United States
| | - Douglas McCarty
- Pfizer Worldwide Research Development and Medicine, Drug Safety Research and Development, Cambridge, Massachusetts, United States
| | - Suryanarayan Somanathan
- Pfizer Worldwide Research Development and Medicine, Drug Safety Research and Development, Cambridge, Massachusetts, United States
| | - Laurence Whiteley
- Pfizer Worldwide Research Development and Medicine, Drug Safety Research and Development, Cambridge, Massachusetts, United States
| |
Collapse
|
4
|
Brady J, Vasiliadou I, Potter V, Benjamin R, Patten P, Cuadrado M, Evans O, Alexander E, Gillham C, Summers J, Ajithkumar T, Bates A, Sanderson R, Kuhnl A, Mikhaeel N. PH-0329 Feasibility and outcome of bridging RT pre CAR-T in DLBCL in one centre with a wide referral network. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07302-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
5
|
Jones K, Webster A, Ntentas G, Brady J, Mikhaeel N. PO-1972 DIBH for mediastinal lymphoma: Implementation and evaluation of a 5-year service. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)08423-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Lyons T, Jahns H, Brady J, O'Hara E, Waters SM, Kenny D, Doyle E, Meade KG. Integrated analyses of the microbiological, immunological and ontological transitions in the calf ileum during early life. Sci Rep 2020; 10:21264. [PMID: 33277514 PMCID: PMC7718239 DOI: 10.1038/s41598-020-77907-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Accepted: 11/09/2020] [Indexed: 02/08/2023] Open
Abstract
Aberdeen Angus calves were sacrificed from immediately post-birth up to 96 days of age (DOA) and ileal samples were collected for microbial, histological and immunological analyses. Firmicutes bacteria were established immediately in the ileum of calves after birth and remained the dominant phyla at all time points from birth until 96 DOA. Temporal shifts in phyla reflected significantly increased Bacteroidetes at birth followed by temporal increases in Actinobacteria abundance over time. At a cellular level, a significant increase in cell density was detected in the ileal villi over time. The innate cell compartment at birth was composed primarily of eosinophils and macrophages with a low proportion of adaptive T lymphocytes; whereas an increase in the relative abundance of T cells (including those in the intra-epithelial layer) was observed over time. The ileal intestinal cells were immunologically competent as assessed by expression levels of genes encoding the inflammasome sensor NLRP3, and inflammatory cytokines IL1A, IL1B and IL33-all of which significantly increased from birth. In contrast, a temporal reduction in genes encoding anti-inflammatory cytokine IL10 was detected from birth. This study provides an integrated baseline of microbiological, histological and immunological data on the immune adaptation of the neonatal ileum to microbial colonisation in calves.
Collapse
Affiliation(s)
- Tamsin Lyons
- Environmental Microbiology Group, School of Biology and Environmental Science and Earth Institute, University College Dublin, Belfield, Ireland
| | - Hanne Jahns
- Pathobiology Section, School of Veterinary Medicine, University College Dublin, Dublin, Ireland
| | - Joseph Brady
- Pathobiology Section, School of Veterinary Medicine, University College Dublin, Dublin, Ireland
| | - Eóin O'Hara
- Animal & Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Grange, County Meath, Ireland.,Department of Agriculture, Food, and Nutritional Sciences, University of Alberta, Edmonton, AB, Canada
| | - Sinéad M Waters
- Animal & Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Grange, County Meath, Ireland
| | - David Kenny
- Animal & Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Grange, County Meath, Ireland
| | - Evelyn Doyle
- Environmental Microbiology Group, School of Biology and Environmental Science and Earth Institute, University College Dublin, Belfield, Ireland
| | - Kieran G Meade
- Animal & Bioscience Research Department, Animal and Grassland Research and Innovation Centre, Teagasc, Grange, County Meath, Ireland. .,School of Agriculture and Food Science, University College Dublin, Dublin 4, Ireland.
| |
Collapse
|
7
|
Hafez O, Brady J, Attallah H, Mikhaeel N. OC-0458: Local tumour control after mediastinal radiotherapy with DIBH and small CTV-PTV margin. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00480-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Shelley C, Brady J, Rahman F, Mikhaeel G. PO-0919: Low vs intermediate dose radiotherapy in head & neck MALT lymphoma with and without Sjogren syndrome. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00936-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
9
|
Maurouard T, Shivakumar R, Brady J. Advancing cellular therapies using clinically scalable engineering of T Cells and NK cells. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
10
|
Motov S, Butt M, Masoudi A, Hossain R, Drapkin J, Likourezos A, Fassassi C, Brady J, Rothberger N, Flom P, Marshall J. 257 Comparison of Analgesic Efficacy of Morphine Sulfate Immediate Release/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet) for Acute Pain in Emergency Department Patients. Ann Emerg Med 2019. [DOI: 10.1016/j.annemergmed.2019.08.215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Owen L, Pleming J, Lisk C, Brady J, Benafif A, Lewis A, Bertfield D, Mani S. 22‘THE FRAILTY JOURNEY – FROM EARLY RECOGNITION TO END OF LIFE’: AN INNOVATIVE MULTIDISCIPLINARY LEARNING EVENT. Age Ageing 2019. [DOI: 10.1093/ageing/afz055.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- L Owen
- Geriatrics Department, Barnet Hospital
| | - J Pleming
- Geriatrics Department, Barnet Hospital
| | - C Lisk
- Geriatrics Department, Barnet Hospital
| | - J Brady
- Geriatrics Department, Barnet Hospital
| | - A Benafif
- Geriatrics Department, Barnet Hospital
| | - A Lewis
- Geriatrics Department, Barnet Hospital
| | | | - S Mani
- Geriatrics Department, Barnet Hospital
| |
Collapse
|
12
|
Noble M, Brady J. Response Rates to Newly Implemented Neoadjuvant TCHP Chemotherapy in the Dorset Cancer Network. Clin Oncol (R Coll Radiol) 2019. [DOI: 10.1016/j.clon.2019.03.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Ronald J, Nixon A, Hatch A, Brady J, Campa M, Devos N, Corcoran D, Hurwitz H, Martin J, Kim C. 04:03 PM Abstract No. 323 Transcatheter arterial embolization increases circulating cell-free DNA in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
14
|
Brady J, Stewart W, Whitney T, Scholljegerdes E, Yeoman C, Waldron D, Musser J, Adams R, Walker J. PSXI-10 Rumen microbial characteristics of goats selectively bred to have greater consumption of Juniperus pinchotii forage. J Anim Sci 2018. [DOI: 10.1093/jas/sky404.789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- J Brady
- Texas A&M AgriLife Research,Stephenville, TX, United States
| | - W Stewart
- Univ. of WY, Dept. of Anim. Sci.,Laramie, United States
| | - T Whitney
- Texas A&M AgriLife Research, San Angelo, TX, United States
| | - E Scholljegerdes
- NM State Univ., Dept. Animal and Range Sci., Las Cruces, NM, United States
| | - C Yeoman
- MT State Univ., Dept Anim. and Range Sci.,Bozeman, MT, United States
| | - D Waldron
- Texas A&M AgriLife Research, San Angelo, TX, United States
| | - J Musser
- Texas A&M University, College of Vet. Medicine and Biomedical Sci.,College Station, TX, United States
| | - R Adams
- Baylor Univ.,Hurricane, UT, United States
| | - J Walker
- Texas A&M AgriLife Research, San Angelo, TX, United States
| |
Collapse
|
15
|
Smeets D, Miller IS, O'Connor DP, Das S, Moran B, Boeckx B, Gaiser T, Betge J, Barat A, Klinger R, van Grieken NCT, Cremolini C, Prenen H, Mazzone M, Depreeuw J, Bacon O, Fender B, Brady J, Hennessy BT, McNamara DA, Kay E, Verheul HM, Maarten N, Gallagher WM, Murphy V, Prehn JHM, Koopman M, Punt CJA, Loupakis F, Ebert MPA, Ylstra B, Lambrechts D, Byrne AT. Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy. Nat Commun 2018; 9:4112. [PMID: 30291241 PMCID: PMC6173768 DOI: 10.1038/s41467-018-06567-6] [Citation(s) in RCA: 46] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Accepted: 09/04/2018] [Indexed: 02/07/2023] Open
Abstract
Increased copy number alterations (CNAs) indicative of chromosomal instability (CIN) have been associated with poor cancer outcome. Here, we study CNAs as potential biomarkers of bevacizumab (BVZ) response in metastatic colorectal cancer (mCRC). We cluster 409 mCRCs in three subclusters characterized by different degrees of CIN. Tumors belonging to intermediate-to-high instability clusters have improved outcome following chemotherapy plus BVZ versus chemotherapy alone. In contrast, low instability tumors, which amongst others consist of POLE-mutated and microsatellite-instable tumors, derive no further benefit from BVZ. This is confirmed in 81 mCRC tumors from the phase 2 MoMa study involving BVZ. CNA clusters overlap with CRC consensus molecular subtypes (CMS); CMS2/4 xenografts correspond to intermediate-to-high instability clusters and respond to FOLFOX chemotherapy plus mouse avastin (B20), while CMS1/3 xenografts match with low instability clusters and fail to respond. Overall, we identify copy number load as a novel potential predictive biomarker of BVZ combination therapy. Increased copy number alterations, indicative of chromosomal instability, is associated with poor cancer outcome. Here, metastatic colorectal cancer patients displaying intermediate-high CIN associate with improved outcome following chemotherapy and bevacizumab treatment, suggesting CIN as a predictive biomarker.
Collapse
Affiliation(s)
- Dominiek Smeets
- VIB Center for Cancer Biology, VIB, Herestraat 49, 3000, Leuven, Belgium.,Department of Human Genetics, University of Leuven (KULeuven), Herestraat 49, 3000, Leuven, Belgium
| | - Ian S Miller
- Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 31A York Street, Dublin, D2, Ireland
| | - Darran P O'Connor
- Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St.Stephen's Green, Dublin, D2, Ireland.,UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D4, Ireland
| | - Sudipto Das
- Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St.Stephen's Green, Dublin, D2, Ireland.,UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D4, Ireland
| | - Bruce Moran
- UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D4, Ireland
| | - Bram Boeckx
- VIB Center for Cancer Biology, VIB, Herestraat 49, 3000, Leuven, Belgium.,Department of Human Genetics, University of Leuven (KULeuven), Herestraat 49, 3000, Leuven, Belgium
| | - Timo Gaiser
- Institute of Pathology, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - Johannes Betge
- Department of Medicine II, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - Ana Barat
- Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 31A York Street, Dublin, D2, Ireland
| | - Rut Klinger
- UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D4, Ireland
| | - Nicole C T van Grieken
- Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
| | - Chiara Cremolini
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Istituto Toscano Tumori, Lungarno Antonio Pacinotti, 43, 56126, Pisa, Italy
| | - Hans Prenen
- Department of Oncology, University Hospital Antwerp, Edegem, 2650, Belgium.,Center for Oncological Research, Antwerp University, 2650, Edegem, Belgium
| | - Massimiliano Mazzone
- VIB Center for Cancer Biology, VIB, Herestraat 49, 3000, Leuven, Belgium.,Department of Oncology, University of Leuven (KULeuven), Herestraat 49, 3000, Leuven, Belgium
| | - Jeroen Depreeuw
- VIB Center for Cancer Biology, VIB, Herestraat 49, 3000, Leuven, Belgium.,Department of Human Genetics, University of Leuven (KULeuven), Herestraat 49, 3000, Leuven, Belgium.,Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals Leuven, KU Leuven, Herestraat 49, 3000, Leuven, Belgium
| | - Orna Bacon
- Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 31A York Street, Dublin, D2, Ireland
| | - Bozena Fender
- OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin, D4, Ireland
| | - Joseph Brady
- Veterinary Pathobiology, School of Veterinary Medicine, University College Dublin, Stillorgan Rd, Belfield, Dublin, D4, Ireland
| | - Bryan T Hennessy
- Department of Surgery, Beaumont Hospital, Beaumont Rd, Beaumont, Dublin, D9, Ireland
| | - Deborah A McNamara
- Department of Surgery, Beaumont Hospital, Beaumont Rd, Beaumont, Dublin, D9, Ireland
| | - Elaine Kay
- Department of Pathology, Beaumont Hospital, Beaumont Rd, Beaumont, Dublin, D9, Ireland
| | - Henk M Verheul
- Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
| | - Neerincx Maarten
- Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
| | - William M Gallagher
- UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D4, Ireland.,OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin, D4, Ireland
| | - Verena Murphy
- Cancer Trials Ireland, Innovation House, Old Finglas Road, Dublin, D9, Ireland
| | - Jochen H M Prehn
- Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 31A York Street, Dublin, D2, Ireland
| | - Miriam Koopman
- Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
| | - Cornelis J A Punt
- Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
| | - Fotios Loupakis
- Oncologia Medica 1, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS, Via Gattamelata, 64, 35128, Padova, Italy
| | - Matthias P A Ebert
- Department of Medicine II, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
| | - Bauke Ylstra
- Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
| | - Diether Lambrechts
- VIB Center for Cancer Biology, VIB, Herestraat 49, 3000, Leuven, Belgium. .,Department of Human Genetics, University of Leuven (KULeuven), Herestraat 49, 3000, Leuven, Belgium.
| | - Annette T Byrne
- Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 31A York Street, Dublin, D2, Ireland.,UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, D4, Ireland
| |
Collapse
|
16
|
Drapkin J, Motov S, Likourezos A, Monfort R, Butt M, Hossain R, Gulati V, Brady J, Mann S, Rothberger N, Marshall J. 1 A Randomized Trial Comparing the Combination of Intravenous Lidocaine and Ketorolac to Either Analgesics Alone for Emergency Department Patients With Acute Renal Colic. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
17
|
Abstract
Aims Little is known about the effect of haemorrhagic shock and resuscitation
on fracture healing. This study used a rabbit model with a femoral
osteotomy and fixation to examine this relationship. Materials and Methods A total of 18 male New Zealand white rabbits underwent femoral
osteotomy with intramedullary fixation with ‘shock’ (n = 9) and
control (n = 9) groups. Shock was induced in the study group by
removal of 35% of the total blood volume 45 minutes before resuscitation
with blood and crystalloid. Fracture healing was monitored for eight weeks
using serum markers of healing and radiographs. Results Four animals were excluded due to postoperative complications.
The serum concentration of osteocalcin was significantly elevated
in the shock group postoperatively (p < 0.0001). There were otherwise
no differences with regard to serum markers of bone healing. The
callus index was consistently increased in the shock group on anteroposterior
(p = 0.0069) and lateral (p = 0.0165) radiographs from three weeks
postoperatively. The control group showed an earlier decrease of
callus index. Radiographic scores were significantly greater in
the control group (p = 0.0025). Conclusion In a rabbit femoral osteotomy model with intramedullary fixation,
haemorrhagic shock and resuscitation produced larger callus but
with evidence of delayed remodelling. Cite this article: Bone Joint J 2018;100-B:1234–40.
Collapse
Affiliation(s)
- J Brady
- Lismore Base Hospital, Lismore, Australia
| | - B M Hardy
- John Hunter Hospital, New Lambton Heights, Australia
| | - O Yoshino
- Austin Hospital, Melbourne, Australia
| | - A Buxton
- University of Newcastle, Newcastle, Australia
| | - A Quail
- School of Medicine and Public Health, University of Newcastle, Australia
| | - Z J Balogh
- University of Newcastle, Newcastle, Australia and Orthopaedic Surgeon, John Hunter Hospital, New Lambton Heights, Australia
| |
Collapse
|
18
|
Stotz MK, Smith BW, Herrygers K, Bidwell C, Brady J, Waddell J. 147 Calpastatin Isoforms Related to Meat Tenderness in Beef Cattle. J Anim Sci 2018. [DOI: 10.1093/jas/sky027.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- M K Stotz
- Tarleton State University, Stephneville, TX
| | - B W Smith
- Tarleton State University, Stephenville, TX
| | | | | | - J Brady
- Texas A&M University, College Station, TX
| | - J Waddell
- Tarleton State University, Stephenville, TX
| |
Collapse
|
19
|
Yoshino O, Brady J, Young K, Hardy B, Matthys R, Buxton T, Appleyard R, Tomka J, Dabirrahmani D, Woodford P, Fadia M, Steck R, Quail A, Richards RG, Balogh ZJ. Reamed locked intramedullary nailing for studying femur fracture and its complications. Eur Cell Mater 2017; 34:99-107. [PMID: 28891043 DOI: 10.22203/ecm.v034a07] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Morbidity associated with femur fractures in polytrauma patients is known to be high. The many unsolved clinical questions include the immunological effect of the fracture and its fixation, timing of fracture fixation, management of fracture non-union, effect of infection and critical size of bone defects. The aim of this study was to establish a clinically-relevant and reproducible animal model with regards to histological, biomechanical and radiological changes during bone healing. A custom-designed intramedullary nail with interlocking system (RabbitNail, RISystem AG, Davos Platz, Switzerland) was used for fixation, following femur fracture. New Zealand White rabbits were assigned to two groups: 1. closed fracture model (CF; non-survival model: n = 6, survival model: n = 3) with unilateral mid-shaft femur fracture created by blunt force; 2. osteotomy model (OT; survival model: n = 14) with unilateral transverse osteotomy creating femur fracture. There were no intraoperative complications and full-weight bearing was achieved in all survival rabbits. Significant periosteal reaction and callus formation were confirmed from 2 weeks postoperatively, with a significant volume formation (739.59 ± 62.14 mm3) at 8 weeks confirmed by micro-computed tomography (µ-CT). 2 months after fixation, there was no difference between the osteotomised and contralateral control femora in respect to the maximum torque (3.47 ± 0.35 N m vs. 3.26 ± 0.37 N m) and total energy (21.11 ± 3.09 N m × degree vs. 20.89 ± 2.63 N m × degree) required to break the femur. The data confirmed that a standardised internal fixation technique with an intramedullary nail for closed fracture or osteotomy produced satisfactory bone healing. It was concluded that important clinically-relevant studies can be conducted using this rabbit model.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Z J Balogh
- Department of Traumatology, University of Newcastle and John Hunter Hospital, 2310 Newcastle, NSW,
| |
Collapse
|
20
|
Brady J, O’Loughlin K. AUSTRALIAN LIVES ALTERED BY PARKINSON’S DISEASE: WORK, RETIREMENT, AND CARE. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.1171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- J. Brady
- Faculty of Health Sciences, University of Sydney, Cremorne, New South Wales, Australia
| | - K. O’Loughlin
- Faculty of Health Sciences, University of Sydney, Cremorne, New South Wales, Australia
| |
Collapse
|
21
|
Craig J, Broghammer J, Kaufman M, Milam D, Cleves M, McClung C, Brady J, Jones L, Gross M, Henry G, Brant W. 011 Outcomes after AUS Replacement due to Cuff Erosion: Results from a Multicenter Retrospective Analysis. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2016.12.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
22
|
Nikolic MZ, Johnson JA, Sun D, Caritg O, Laresgoiti U, Brady J, Allen G, Giangreco A, Rawlins EL. T5 Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3d organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
23
|
Brady J, Costantini C, Sagnon N, Gibson G, Coluzzi M. The role of body odours in the relative attractiveness of different men to malarial vectors in Burkina Faso. Annals of Tropical Medicine & Parasitology 2016. [DOI: 10.1080/00034983.1997.11813252] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|
24
|
Rahman F, Brady J, Galli S, Mikhaeel N. PO-0668: Outcome of low and intermediate dose radiotherapy in head and neck MALT lymphoma. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31918-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
25
|
Garza-Cuartero L, McCarthy E, Brady J, Cassidy J, Hamilton C, Sekiya M, NcNair J, Mulcahy G. Development of an in vitro model of the early-stage bovine tuberculous granuloma using Mycobacterium bovis-BCG. Vet Immunol Immunopathol 2015; 168:249-57. [PMID: 26553300 DOI: 10.1016/j.vetimm.2015.10.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2015] [Revised: 10/09/2015] [Accepted: 10/14/2015] [Indexed: 01/03/2023]
Abstract
Mycobacterium bovis causes 3.1% of human tuberculosis cases, as described by the World Health Organisation. In cattle, this organism causes bovine tuberculosis (BTB) which can have a prevalence of up to 39.5% in some developing countries. In developed countries, although the prevalence of BTB has been reduced through eradication programmes, complete eradication has in some cases proved elusive, with prevalences in cattle of 0.5% in the Republic of Ireland and of 4.3% in the UK. As the tuberculous granuloma is the fundamental lesion that reflects the pathogenesis, immune control and progression of BTB, we aimed to develop an in vitro model of the early-stage bovine tuberculous granuloma, in order to model the early stages of BTB, while also reducing the use of experimentally infected animals. In vitro models of human and ovine mycobacterial granulomas have previously been developed; however, so far, there is no model for the BTB granuloma. As the disease in cattle differs in a number of ways from that in other species, we consider this to be a significant gap in the tools available to study the pathogenesis of BTB. By combining bovine monocyte-derived macrophages infected with M. bovis-BCG and autologous lymphocytes we have developed an early-stage tuberculous bovine granuloma model. In the model, 3D cell aggregations formed a spherical-shape that grew for up to 11 days post-infection. This bovine tuberculous granuloma model can aid in the study of such lesion development, and in comparative studies of pathogenesis, such as, for example, the question of mycobacterial latency in bovine tuberculosis.
Collapse
Affiliation(s)
- Laura Garza-Cuartero
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
| | - Elaine McCarthy
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | - Joseph Brady
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | - Joseph Cassidy
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | - Clare Hamilton
- Moredun Research Institute, Penicuik, Midlothian, Edinburgh EH260PZ, Scotland, United Kingdom
| | - Mary Sekiya
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| | - Jim NcNair
- Agri-Food and Biosciences Institute, Veterinary Sciences Division, Stoney Road, Stormont, Belfast BT4 3SD, Northern Ireland, United Kingdom
| | - Grace Mulcahy
- School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
| |
Collapse
|
26
|
French J, Purificacion S, Brown E, MacDonald R, Wilson L, Kumar E, Bird L, Brady J, Milosevic M, Mitera G. Each Cancer Journey Begins With One Shared Step: Patient Engagement and Radiation Therapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1831] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
27
|
Hawthorne W, Hawkes J, Salvaris E, Liuwantara D, Barlow H, Phillips P, Robson S, Brady J, Lew A, Mark N, OʼConnell P, Cowan P. Survival of Genetically Modified Porcine Neonatal Islet Xenografts in Baboons. Transplantation 2014. [DOI: 10.1097/00007890-201407151-01368] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Holzinger D, Lohse P, Faßl S, Austermann J, Vogl T, de Jager W, Holland S, Gattorno M, Rodriguez-Gallego C, Arostegui J, Fessatou S, Isidor B, Ito K, Epple HJ, Bernstein J, Jeng M, Lionetti G, Ong P, Hinze C, Sampson B, Sunderkoetter C, Foell D, Chae J, Ombrello A, Brady J, Aksentijevich I, Roth J. PW02-018 - Impact of PSTPIP1 mutaions on clinical phenotype. Pediatr Rheumatol Online J 2013. [PMCID: PMC3953041 DOI: 10.1186/1546-0096-11-s1-a158] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
|
29
|
Kieran M, O’Sullivan D, Brady J, McQuaid S, Meegan C. DGI-025 Development of a Protocol For the Treatment of Vitamin D Deficiency/Insufficiency in Adults. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
30
|
Kieran M, Gavin C, O’Shea L, Brady J, Meegan C. DGI-002 Adrenal Insufficiency Induced by a Chinese Herbal Medicine. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
31
|
Murphy TM, Mullins N, Ryan M, Foster T, Kelly C, McClelland R, O'Grady J, Corcoran E, Brady J, Reilly M, Jeffers A, Brown K, Maher A, Bannan N, Casement A, Lynch D, Bolger S, Buckley A, Quinlivan L, Daly L, Kelleher C, Malone KM. Genetic variation in DNMT3B and increased global DNA methylation is associated with suicide attempts in psychiatric patients. Genes Brain Behav 2013; 12:125-32. [PMID: 23025623 DOI: 10.1111/j.1601-183x.2012.00865.x] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/05/2012] [Revised: 08/17/2012] [Accepted: 09/27/2012] [Indexed: 11/28/2022]
Abstract
Recently, a significant epigenetic component in the pathology of suicide has been realized. Here we investigate candidate functional SNPs in epigenetic-regulatory genes, DNMT1 and DNMT3B, for association with suicide attempt (SA) among patients with co-existing psychiatric illness. In addition, global DNA methylation levels [5-methyl cytosine (5-mC%)] between SA and psychiatric controls were quantified using the Methylflash Methylated DNA Quantification Kit. DNA was obtained from blood of 79 suicide attempters and 80 non-attempters, assessed for DSM-IV Axis I disorders. Functional SNPs were selected for each gene (DNMT1; n = 7, DNMT3B; n = 10), and genotyped. A SNP (rs2424932) residing in the 3' UTR of the DNMT3B gene was associated with SA compared with a non-attempter control group (P = 0.001; Chi-squared test, Bonferroni adjusted P value = 0.02). Moreover, haplotype analysis identified a DNMT3B haplotype which differed between cases and controls, however this association did not hold after Bonferroni correction (P = 0.01, Bonferroni adjusted P value = 0.56). Global methylation analysis showed that psychiatric patients with a history of SA had significantly higher levels of global DNA methylation compared with controls (P = 0.018, Student's t-test). In conclusion, this is the first report investigating polymorphisms in DNMT genes and global DNA methylation quantification in SA risk. Preliminary findings suggest that allelic variability in DNMT3B may be relevant to the underlying diathesis for suicidal acts and our findings support the hypothesis that aberrant DNA methylation profiles may contribute to the biology of suicidal acts. Thus, analysis of global DNA hypermethylation in blood may represent a biomarker for increased SA risk in psychiatric patients.
Collapse
Affiliation(s)
- T M Murphy
- Department of Psychiatry and Mental Health Research & Education and Research Centre, St Vincent's University Hospital, and School of Medicine & Medical Science, University College Dublin, Dublin 4, Ireland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Rodríguez-Lecompte JC, Yitbarek A, Brady J, Sharif S, Cavanagh MD, Crow G, Guenter W, House JD, Camelo-Jaimes G. The effect of microbial-nutrient interaction on the immune system of young chicks after early probiotic and organic acid administration1. J Anim Sci 2012; 90:2246-54. [DOI: 10.2527/jas.2011-4184] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - A. Yitbarek
- Department of Animal Science, University of Manitoba, Winnipeg R3T 2N2, Canada
| | - J. Brady
- Department of Animal Science, University of Manitoba, Winnipeg R3T 2N2, Canada
| | - S. Sharif
- Department of Pathobiology, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - M. D. Cavanagh
- Department of Animal Science, University of Manitoba, Winnipeg R3T 2N2, Canada
| | - G. Crow
- Department of Animal Science, University of Manitoba, Winnipeg R3T 2N2, Canada
| | - W. Guenter
- Department of Animal Science, University of Manitoba, Winnipeg R3T 2N2, Canada
| | - J. D. House
- Department of Human Nutritional Science, University of Manitoba, Winnipeg R3T 2N2, Canada
| | | |
Collapse
|
33
|
Yitbarek A, Echeverry H, Brady J, Hernandez-Doria J, Camelo-Jaimes G, Sharif S, Guenter W, House J, Rodriguez-Lecompte J. Innate immune response to yeast-derived carbohydrates in broiler chickens fed organic diets and challenged with Clostridium perfringens. Poult Sci 2012; 91:1105-12. [DOI: 10.3382/ps.2011-02109] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
34
|
Criswell KA, Cook JC, Morse D, Lawton M, Somps C, Obert L, Roy M, Sokolowski S, Koza-Taylor P, Colangelo J, Navetta K, Brady J, Pegg D, Wojcinski Z, Rahbari R, Duddy S, Anderson T. Pregabalin Induces Hepatic Hypoxia and Increases EndothelialCell Proliferation in Mice, a Process Inhibited by DietaryVitamin E Supplementation. Toxicol Sci 2012; 128:42-56. [DOI: 10.1093/toxsci/kfs148] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
35
|
|
36
|
Ratkevicius A, Joyson A, Selmer I, Dhanani T, Grierson C, Tommasi AM, DeVries A, Rauchhaus P, Crowther D, Alesci S, Yaworsky P, Gilbert F, Redpath TW, Brady J, Fearon KCH, Reid DM, Greig CA, Wackerhage H. Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men. J Gerontol A Biol Sci Med Sci 2011; 66:620-6. [DOI: 10.1093/gerona/glr025] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
|
37
|
Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, Hagan R, Duggan M, Jordan S, McKenna M, Hutchinson M, Tubridy N. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 2011; 82:317-22. [PMID: 21248317 DOI: 10.1136/jnnp.2010.220988] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND The relationship between prevalence of multiple sclerosis (MS) and latitude may be due to both genetic and environmental factors. The hypothesis that, in Ireland, MS prevalence is increasing and that north-south differences relate to variation in serum 25-hydroxyvitamin D (25(OH)D) levels was tested in this study. PATIENTS AND METHODS Patients and matched control subjects were identified in counties Donegal, Wexford and South Dublin through multiple sources. Prevalence was determined. Blood samples were taken for serum 25(OH)D and serum intact parathyroid hormone measurement, and DNA was extracted. RESULTS Prevalence in 2007 was significantly greater in Donegal (northwest) (290.3/105, 95% CI 262.3 to 321.7) compared with 2001 (184.6/105; 162 to 209.5). In Wexford (southeast), there was a non-significant increase in prevalence in 2007 compared with 2001. Prevalence was significantly higher in Donegal than in Wexford (144.8/105; 126.7 to 167.8, p<0.0001) and South Dublin (127.8/105; 111.3 to 148.2, p<0.0001). Overall, mean 25(OH)D levels were low and did not differ between patients (38.6 nmol/l) and controls (36.4 nmol/l) However, significantly more patients than controls had 25(OH)D levels <25 nmol/l (deficiency) (p=0.004). Levels of 25(OH)D (mean 50.74 nmol/l) were significantly higher in South Dublin (area with lowest prevalence) (p<0.0001) than in Donegal or Wexford. HLA DRB1*15 occurred most frequently in Donegal (greatest MS prevalence) and least frequently in South Dublin. CONCLUSION Vitamin D deficiency is common in Ireland. Latitudinal variation in MS probably relates to an interaction between genetic factors and environment (25(OH)D levels), and MS risk may be modified by vitamin D in genetically susceptible individuals.
Collapse
Affiliation(s)
- R Lonergan
- Department of Neurology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Grierson C, Miller D, LaPan P, Brady J. Utility of combining MMP-9 enzyme-linked immunosorbent assay and MMP-9 activity assay data to monitor plasma enzyme specific activity. Anal Biochem 2010; 404:232-4. [DOI: 10.1016/j.ab.2010.05.020] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2010] [Revised: 05/17/2010] [Accepted: 05/20/2010] [Indexed: 11/29/2022]
|
39
|
Cawood TJ, Bashir M, Brady J, Murray B, Murray PT, O'Shea D. Urinary collagen IV and πGST: potential biomarkers for detecting localized kidney injury in diabetes--a pilot study. Am J Nephrol 2010; 32:219-225. [PMID: 20664197 DOI: 10.1159/000317531] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2010] [Accepted: 06/19/2010] [Indexed: 11/19/2022]
Abstract
BACKGROUND/AIMS Urinary biomarkers can identify damage to specific parts of the nephron. We performed a cross-sectional study to characterise the pattern of diabetic nephropathy using urinary biomarkers of glomerular fibrosis (collagen IV), proximal tubular damage (α-glutathione-S-transferase, GST) and distal tubular damage (πGST). METHODS Clinical data from 457 unselected patients attending a hospital diabetes clinic were collected. Spot urine samples were analysed for albumin and creatinine. Biomarkers were measured by enzyme-linked immunosorbent assay, and corrected to urinary creatinine. RESULTS All 3 biomarkers correlated weakly with albumin/creatinine ratios (Pearson correlation <0.2, p values <0.001). The most common abnormality was elevated urinary collagen IV (glomerular, 35%) compared to αGST (proximal tubule, 18%) or πGST (distal tubule, 15%). The proportion of patients with abnormal biomarker results increased across the normo-, micro- and macroalbuminuria groups, with collagen IV (26, 58, 65%) and πGST (11, 25, 35%) but not αGST. CONCLUSION In patients with diabetes, these urinary biomarkers appear to identify renal damage that is related to, but distinct from, urine albumin/creatinine ratios. The markers of glomerular fibrosis and distal tubular damage related most closely to the degree of albuminuria. Longitudinal studies are now required to assess whether these biomarkers can detect early renal disease with greater specificity and sensitivity than the albumin/creatinine ratio.
Collapse
|
40
|
Sabharwal A, Corrie PG, Midgley RS, Palmer C, Brady J, Mortimer P, Watson AJ, Margison GP, Middleton MR. A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer. Cancer Chemother Pharmacol 2009; 66:829-35. [DOI: 10.1007/s00280-009-1225-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2009] [Accepted: 12/13/2009] [Indexed: 11/24/2022]
|
41
|
Patel C, Ullal A, Roberts M, Brady J, Birch P, Bulmer JN, Wadehra V. Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology. Cytopathology 2009; 20:380-7. [DOI: 10.1111/j.1365-2303.2008.00621.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
42
|
Ingwell L, Brady J, Fitzpatrick M, Maynard B, Casagrande R, Preisser E. Intraspecific Variation inTsuga canadensisFoliar Chemistry. Northeast Nat (Steuben) 2009. [DOI: 10.1656/045.016.n408] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
43
|
Oxley J, Smith J, Luo W, Brady J. Determining the Vapor Pressures of Diacetone Diperoxide (DADP) and Hexamethylene Triperoxide Diamine (HMTD). Propellants, Explosives, Pyrotechnics 2009. [DOI: 10.1002/prep.200800073] [Citation(s) in RCA: 67] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
44
|
Brady J, Middleton M, Midgley RS, Mallath MK, Corrie P, Sirohi B, Chau I, Digumarti R, Botbyl J, Lager JJ. A phase I study of pazopanib in combination with FOLFOX 6 or capeOx in subjects with colorectal cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.4133] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4133 Background: Pazopanib (paz) is a tyrosine kinase inhibitor of VEGFR-1, -2, -3, PDGF-α, -β, and c-kit. Inhibition of angiogenic pathways in combination with chemotherapy has been shown to benefit patients (pts) with colorectal cancer (CRC). Methods: Pts with previously untreated advanced or metastatic CRC and adequate organ function were assigned to paz with FOLFOX6 (FO) or capeOx (CO) by their physician. Doses of paz were escalated with full strength chemotherapy, starting at 400mg daily. The optimally tolerated regimen (OTR) was the combination dose at which <1/6 pts experienced dose-limiting toxicity (DLT). Results: Fifty pts were enrolled in FO (paz 400 mg, n=6; 800, 15), CO (400, 12; 800, 9) and reduced capecitabine (rc) CO (800, 8) cohorts: median age = 55.5, M/F = 37/13. Pts have remained on therapy for a median of 3 (range 0–17) months. Three pts remain on study. Safety data is available on 41. The most common AEs are summarized in the table below. The OTR was exceeded with CO in combination with 800 mg and 400 mg of pazopanib, but was not exceeded with 800 mg pazopanib when capecitabine was reduced to 850 mg/m2 twice daily or with FO with 800 mg pazopanib. Efficacy and pharmacokinetic analyses are ongoing. Conclusions: The OTRs were achieved at 800 mg paz with full-dose FO, and at 800mg paz with rcCO. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- J. Brady
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - M. Middleton
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - R. S. Midgley
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - M. K. Mallath
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - P. Corrie
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - B. Sirohi
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - I. Chau
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - R. Digumarti
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - J. Botbyl
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| | - J. J. Lager
- Churchill Hospital, Oxford, United Kingdom; Tata Memorial Hospital, Mumbai, India; Addenbrooke's Hospital, Cambridge, United Kingdom; Royal Marsden Hospital, London, United Kingdom; Nizam's Insitute of Medical Sciences, Hyderabad, India; GlaxoSmithKline, Research Triangle Park, NC
| |
Collapse
|
45
|
Oxley J, Smith J, Brady J, Dubnikova F, Kosloff R, Zeiri L, Zeiri Y. Raman and infrared fingerprint spectroscopy of peroxide-based explosives. Appl Spectrosc 2008; 62:906-15. [PMID: 18702865 DOI: 10.1366/000370208785284420] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
A comparative study of the vibrational spectroscopy of peroxide-based explosives is presented. Triacetone triperoxide (TATP) and hexamethyl-enetriperoxide-diamine (HMTD), now commonly used by terrorists, are examined as well as other peroxide-ring structures: DADP (diacetone diperoxide); TPTP [3,3,6,6,9,9-Hexaethyl-1,2,4,5,7,8-hexaoxo-nonane (tripentanone triperoxide)]; DCypDp {6,7,13,14-Tetraoxadispiro [4.2.4.2]tetradecane (dicyclopentanone diperoxide)}; TCypDp {6,7,15,16,22,23-Hexaoxatrispiro[4.2.4.2.4.2] henicosane (tricyclopentanone triperoxide)}; DCyhDp {7,8,15,16-tetraoxadispiro [5.2.5.2] hexadecane (dicyclohexanone diperoxide)}; and TCyhTp {7,8,14,15,21,22-hexaoxatrispiro [5.2.5.2.5.2] tetracosane (tricyclohexanone triperoxide)}. Both Raman and infrared (IR) spectra were measured and compared to theoretical calculations. The calculated spectra were obtained by calculation of the harmonic frequencies of the studied compounds, at the density functional theory (DFT) B3LYP/cc-pVDZ level of theory, and by the use of scaling factors. It is found that the vibrational features related to the peroxide bonds are strongly mixed. As a result, the spectrum is congested and highly sensitive to minor changes in the molecule.
Collapse
Affiliation(s)
- Jimmie Oxley
- Chemistry Department, University of Rhode Island, Kingston, Rhode Island, USA.
| | | | | | | | | | | | | |
Collapse
|
46
|
Amato RJ, Jac J, Harris P, Dalton M, Saxena S, Monzon F, Zhai J, Brady J, Willis JP. A phase II trial of intra-patient dose escalated-sorafenib in patients (pts) with metastatic renal cell cancer (MRCC). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.5122] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
47
|
Agger EM, Cassidy JP, Brady J, Korsholm KS, Vingsbo-Lundberg C, Andersen P. Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection. Immunology 2008; 124:175-85. [PMID: 18201185 DOI: 10.1111/j.1365-2567.2007.02751.x] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
It is known that protection against tuberculosis is mediated primarily by T helper type 1 (Th1) cells but the influence of the Th1/Th2 balance of a vaccination response on the subsequent protection and pathology during infection has not been studied in detail. We designed a panel of Ag85B-ESAT-6 subunit vaccines based on adjuvants with different Th1/Th2-promoting activities and studied cellular responses, bacterial replication and pathology in the lungs of mice infected with Mycobacterium tuberculosis. All vaccines induced cell-mediated and humoral responses but with markedly different interferon-gamma : interleukin-5 (IFN-gamma : IL-5) and immunoglobulin G1 (IgG1) : IgG2 ratios. The vaccines promoted different levels of control of bacterial replication with the most efficient protection being exerted by cationic liposomes containing monophosphoryl lipid A and low to completely absent immunity with conventional aluminium. The level of protection correlated with the amount of IFN-gamma produced in response to the vaccine whereas there was no inverse correlation with the level of IL-5. Characterizing a protective response was an accelerated recruitment of IL-17 and IFN-gamma-producing lymphocytes resulting in the early formation of granulomas containing clustered inducible nitric oxide synthase-activated macrophages. In comparison, non-protected mice exhibited a different inflammatory infiltrate rich in neutrophil granulocytes. This study indicates that the adjuvant component of a tuberculosis vaccine may be crucial in determining the kinetics by which effective granulomas, pivotal in controlling bacterial growth, are formed.
Collapse
Affiliation(s)
- Else Marie Agger
- Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
| | | | | | | | | | | |
Collapse
|
48
|
Bonome T, Samimi G, Randonovich M, Brady J, Ghosh S, Ng S, Mok SC, Birrer MJ. A stromal-associated gene expression signature predicting for survival in a series of patients with advanced high-grade serous ovarian cancer. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.5552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5552 Background: Prognostic gene expression signatures have been derived for undissected serous ovarian epithelial tumors, yet the specific contribution of stromal cells to patient survival has not been addressed. The aim of this study is to identify stromal genes impacting patient survival in the context of serous ovarian cancer. Methods: Expression profiling utilizing Affymetrix U133 Plus 2.0 oligonucleotide arrays was completed for 50 microdissected stromal samples derived from high-grade, late-stage serous tumors displaying a broad spectrum of survival endpoints. A semi-supervised dimension reduction method employing multivariate Cox regression and principal components analysis was applied to the expression data to identify genes associated with patient survival and establish a predictive model. qRT-PCR was employed to validate the microarray expression data. Results: Cox regression analysis identified 267 significant genes. The first 6 principal components of these genes, representing >65% of total variance, entered a multivariate Cox model through which the relative hazard of future patients can be predicted. To confirm our finding, the microarray data underwent leave-one-out validation. The patients were equally divided into low- and high-risk groups and non-parametric Kaplan-Meier analysis and log rank test demonstrated the two groups were significantly different in survival (p = 0.0115). Genes associated with cell survival and migration were identified in the prognostic signature. For validation, qRT-PCR data for all 50 specimens was correlated with microarray expression values for a series of select prognostic genes. Conculsions: In this study, we characterized and validated a stromal dervied prognostic signature associated with poor patient survival. Contained in this novel predictor may be stromal targets suitable for the design of new therapeutic interventions, or use as independent diagnostic markers. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- T. Bonome
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - G. Samimi
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - M. Randonovich
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - J. Brady
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - S. Ghosh
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - S. Ng
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - S. C. Mok
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - M. J. Birrer
- National Cancer Institute, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| |
Collapse
|
49
|
Ozbun L, Bonome T, Radonovich M, Pise-Masison C, Brady J, Caplen N, Johnson M, Mok SC, Birrer MJ. Use of predictive gene expression signature from advanced-stage serous papillary ovarian cancer to identify biologically relevant molecular targets for chemoresponse. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.5500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5500 Background: The aim of our study was to develop and validate a gene expression signature predictive for chemoresponse in advanced stage serous papillary ovarian cancer. Methods: Gene expression profiling was performed on 52 chemonaive, microdissected advanced stage, high-grade papillary serous ovarian cancers using Affymetrix whole-genome microarrays. Patient samples were grouped based on chemoresponse. 19 nonresponders were refractory to chemotherapy, 14 responders relapsing 6 months were considered chemosensitive. Each group was divided into training/validation sets. To generate a predictive gene signature, class prediction algorithms were applied to genes differentially expressed between chemosensitive/resistant or chemosensitive/refractory tumors (p<0.001) using leave-one-out cross-validation. Array validation was performed by qRT-PCR. Select genes underwent biological validation in a series of ovarian cancer cell lines. Results: 31 genes predictive for resistance and 105 genes predictive for refractory to chemotherapy were identified. Percentages of arrays accurately predicted in independent validation sets were 90% (9/10) for resistant and 92% (12/13) for refractory gene signatures. Correlations between microarray/qRT-PCR data were robust for both resistant (17/23 genes) and refractory gene signatures (25/34 genes). Data mining of the predictive signatures using PathwayStudio software identified several biological processes (collagen regulation, apoptosis, cell survival, and DNA repair) implicated in conferring resistance to chemotherapy. We transiently transfected RNAi molecules to silence several signature genes and determine their contribution to taxol/cisplatin sensitivity in a series ofl ovarian cancer cell lines. Preliminary data showed DUSP1 gene expression knockdown potentiated cisplatin sensitivity in SKOV3/OVCA429 cell lines, while POLH knockdown potentiated cisplatin sensitivity in OVCA429/OVCA420 cell lines. Conclusions: A gene expression signature predicts for chemoresponse in ovarian cancers, and has identified novel targets of biological/therapeutic interest. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- L. Ozbun
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - T. Bonome
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - M. Radonovich
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - C. Pise-Masison
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - J. Brady
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - N. Caplen
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - M. Johnson
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - S. C. Mok
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| | - M. J. Birrer
- NIH/NCI, Bethesda, MD; Brigham and Women’s Hospital, Boston, MA
| |
Collapse
|
50
|
Patel CJ, Ullal A, Roberts M, Brady J, Bulmer JN, Wadehra V. O-13 ENDOMETRIAL CARCINOMA DETECTED WITH SUREPATH LIQUID BASED CERVICAL CYTOLOGY: COMPARISON WITH CONVENTIONAL CERVICAL CYTOLOGY. Cytopathology 2006. [DOI: 10.1111/j.1365-2303.2006.00392_12_4.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|